Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1488010Generated: November 1, 2026

4-(Piperidin-4-yl)benzonitrile--hydrogen chloride (1/1) → 4-(1-(3-(2-(2-(Azetidin-1-yl)ethyl)-4-chloro-1H-imidazol-5-yl)-4-methylbenzoyl)azetidin-3-yl)benzonitrile

https://huagongshe.com/reaction/1488010

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-(Piperidin-4-yl)benzonitrile--hydrogen chloride (1/1)HCID 19391618—
Reactant4-(Azetidin-3-yl)benzonitrile hydrochlorideHCID 55254991—
ReactantHCID 178425887HCID 178425887—
ReactantHCID 178494679HCID 178494679—
Product4-(1-(3-(2-(2-(Azetidin-1-yl)ethyl)-4-chloro-1H-imidazol-5-yl)-4-methylbenzoyl)azetidin-3-yl)benzonitrileHCID 178425794—

Reaction Steps

The title compound was prepared using standard chemical manipulations and procedures similar to those used for the preparation of compound 27, except 3-(2-(2-(azetidin-1-yl)ethyl)-4-chloro-1H-imidazol-5-yl)-4-methylbenzoic acid (compound 157.3) was used in place of 3-(4-chloro-2-(methoxymethyl)-1H-imidazol-5-yl)-4-methylbenzoic acid (compound 27.5) and 4-(azetidin-3-yl)benzonitrile hydrochloride (compound 5.2) was used in place of 4-(piperidin-4-yl)benzonitrile hydrochloride (compound 1.2). m/z (ES+) 460 (M+H)+.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09428502B2
Source datasetuspto-grants-2016_08
ORD IDord-f781eb98f9084c219e1663ddc33644ea
Source noteuspto-grants-2016_08